Similar articles

• MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.

  Jensen MC, Brant-Zawadzki M. Jensen MC, et al. AJR Am J Roentgenol. 1993 Jan;160(1):153-7. doi: 10.2214/ajr.160.1.8416615. AJR Am J Roentgenol. 1993. PMID: 8416615
• [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].

  Higer HP, Just M, Grigat M, Meindl S, Jungke M, Bielke G, Pedrosa P, Kunze S, Voth D. Higer HP, et al. Rofo. 1988 Mar;148(3):307-13. doi: 10.1055/s-2008-1048198. Rofo. 1988. PMID: 2832897 German.
• Magnetic resonance imaging contrast agents.

  Runge VM. Runge VM. Curr Opin Radiol. 1992 Feb;4(1):3-12. Curr Opin Radiol. 1992. PMID: 1739599
• Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.

  Beltran J, Chandnani V, McGhee RA Jr, Kursunoglu-Brahme S. Beltran J, et al. AJR Am J Roentgenol. 1991 Mar;156(3):457-66. doi: 10.2214/ajr.156.3.1899738. AJR Am J Roentgenol. 1991. PMID: 1899738 Review.
• MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.

  Braffman BH, Bilaniuk LT, Naidich TP, Altman NR, Post MJ, Quencer RM, Zimmerman RA, Brody BA. Braffman BH, et al. Radiology. 1992 Apr;183(1):227-38. doi: 10.1148/radiology.183.1.1549677. Radiology. 1992. PMID: 1549677 Review.